12/09/2024
3:30 PM | Lineage Cell Therapeutics (Filer)
| Form DEF 14A | |
11/29/2024
3:30 PM | Lineage Cell Therapeutics (Filer)
| Form PRE 14A | |
11/26/2024
3:55 PM | Lineage Cell Therapeutics (Issuer)
Samuel George A. III (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/26/2024
3:58 PM | Howe Jill Ann (Reporting)
Lineage Cell Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/22/2024
8:00 AM | Culley Brian M (Reporting)
Lineage Cell Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/21/2024
7:05 PM | BROADWOOD PARTNERS, L.P. (Filed by)
Lineage Cell Therapeutics (Subject)
| Form SC 13D/A | |
11/21/2024
7:55 AM | Lineage Cell Therapeutics (Filer)
| Form 424B5 | |
|
11/20/2024
4:08 PM | Lineage Cell Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/22/2024
2:24 PM | BlackRock, Inc. (Filed by)
Lineage Cell Therapeutics (Subject)
| Form SC 13G | |
08/19/2024
5:24 PM | Howe Jill Ann (Reporting)
Lineage Cell Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/03/2024
1:00 PM | BRADSHER NEAL C (Reporting)
Lineage Cell Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/13/2024
3:30 PM | Lineage Cell Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/28/2024
8:11 AM | Culley Brian M (Reporting)
Lineage Cell Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/14/2024
11:15 PM | Lineage Cell Therapeutics (Filer)
| Form EFFECT | |
05/14/2024
3:39 PM | Lineage Cell Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/09/2024
3:10 PM | Lineage Cell Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/29/2024
3:50 PM | Lineage Cell Therapeutics (Filer)
| Form ARS | |
04/29/2024
3:40 PM | Lineage Cell Therapeutics (Filer)
| Form DEFA14A | |
03/22/2024
3:32 PM | Lineage Cell Therapeutics (Filer)
| Form 424B5 | |
03/07/2024
4:17 PM | Lineage Cell Therapeutics (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
02/15/2024
4:27 PM | Lineage Cell Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/12/2024
8:27 PM | Culley Brian M (Reporting)
Lineage Cell Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/12/2024
8:30 PM | Lineage Cell Therapeutics (Issuer)
Samuel George A. III (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/08/2024
5:57 PM | BROADWOOD PARTNERS, L.P. (Filed by)
Lineage Cell Therapeutics (Subject)
| Form SC 13D/A | |
02/08/2024
5:58 PM | BRADSHER NEAL C (Reporting)
BROADWOOD CAPITAL INC (Reporting)
BROADWOOD PARTNERS, L.P. (Reporting)
Lineage Cell Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/08/2024
6:00 PM | BAILEY DON M (Reporting)
Lineage Cell Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/06/2024
8:00 AM | Lineage Cell Therapeutics (Filer)
| Form 424B5 | |
02/06/2024
8:20 AM | Lineage Cell Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/06/2024
8:25 AM | Lineage Cell Therapeutics (Filer)
| Form 424B5 | |
01/02/2024
6:08 PM | Jayasuriya Anula (Reporting)
Lineage Cell Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
Free LCTX Stock Alerts